Results 61 to 70 of about 6,742 (131)

Evaluation of the stability of cucurbit[8]uril-based ternary host-guest complexation in physiological environment and the fabrication of a supramolecular theranostic nanomedicine. [PDF]

J Nanobiotechnology, 2021
Wu H, Chen Z, Qi S, Bai B, Ye J, Wu D, Shen J, Kang F, Yu G.   +8 more
europepmc   +1 more source

Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics

Bioactive Materials
The integration of artificial intelligence, protein engineering, and sustainable nanomedicine is driving a paradigm shift in theranostics by enabling highly precise disease diagnosis and targeted therapy.
Donya Esmaeilpour, Michael R. Hamblin, Jianlin Cheng, Arezoo Khosravi, Jian Liu, Atefeh Zarepour, Ali Zarrabi, Mika Sillanpää, Ehsan Nazarzadeh Zare, Jianliang Shen, Hassan Karimi-Maleh   +10 more
doaj   +1 more source

Mechanisms of Action of AGuIX as a Pan-Cancer Nano-Radiosensitizer: A Comprehensive Review

Pharmaceuticals
Objective: This review provides an overview of the current knowledge regarding the mechanisms of action of AGuIX, a clinical-stage theranostic nano-radiosensitizer composed of gadolinium.
Clémentine Aubrun, Tristan Doussineau, Léna Carmès, Aurélien Meyzaud, Fabien Boux, Sandrine Dufort, Adeline Delfour, Olivier De Beaumont, Céline Mirjolet, Géraldine Le Duc   +9 more
doaj   +1 more source

Theranostic nanoparticles and their applications in Alzheimer’s disease

İstanbul Journal of Pharmacy
Nanotechnology is the field of science that investigates materials at the atomic scale and designs mate5 rials with unique qualities via changes in their molecular features.
Derya Akyüz Şengün, Nagehan Ersoy Tunalı   +1 more
doaj   +1 more source

Mesoporous silica nanoparticle-based nanomedicine: Preparation, functional modification, and theranostic applications

Materials Today Bio
Mesoporous silica nanoparticles (MSNs) have emerged as cornerstone biomaterials for nanomedicine due to their highly tunable physicochemical properties. This review highlights recent breakthroughs in MSN-based platforms for disease theranostics.
Yuying Liu, Man Zhao, Meihuan Zhang, Bin Yang, Yun-Kun Qi, Qinrui Fu   +5 more
doaj   +1 more source

Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma. [PDF]

Adv Sci (Weinh), 2020
Tan J, Duan X, Zhang F, Ban X, Mao J, Cao M, Han S, Shuai X, Shen J.   +8 more
europepmc   +1 more source

Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene. [PDF]

Int J Nanomedicine, 2020
Patil BR, Kang SY, Jung DH, Avaji PG, Jun YJ, Lee HJ, Sohn YS.   +6 more
europepmc   +1 more source

Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles

Advanced Science
Atherosclerosis, a multifaceted chronic inflammatory disease, has a profound impact on cardiovascular health. However, the critical limitations of atherosclerosis management include the delayed detection of advanced stages, the intricate assessment of ...
Shi Wang, Hongliang He, Yu Mao, Yu Zhang, Ning Gu   +4 more
doaj   +1 more source

Metal-based nanomedicines for cancer theranostics

Military Medical Research
Abstract The heterogeneity and invasiveness of cancer cells pose serious challenges in cancer diagnosis and treatment. Advancements and innovations in metal-based nanomedicines provide novel avenues for addressing these challenges. Metal-based nanomedicines possess unique physicochemical properties that enable their interaction with living ...
Hai-Jia Yu, Jian-Hua Liu, Wei Liu, Rui Niu, Bin Zhang, Yuan Xiong, Yang Liu, Ying-Hui Wang, Hong-Jie Zhang   +8 more
openaire   +1 more source

Targeted theranostic nanomedicine using targeted CT-imageable particles that release tebentafusp. [PDF]

Jpn J Radiol
Harada S, Sato T, Yoshioka K.
europepmc   +1 more source